David P Southwell T Scan Therapeutics, Inc. (TCRX) insider trading activity

David P Southwell is Chief Executive Officer of TScan Therapeutics, Inc.. Currently has a direct ownership of 171,569 shares of TCRX, which is worth approximately $706,864. The most recent transaction as insider was on May 18, 2022, when has been sold 25,000 shares (Voting Common Stock) at a price of $3.59 per share, resulting in proceeds of $89,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K

0% 3M change

0% 12M change

Total Value Held $706,864

DAVID P SOUTHWELL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 18 2022	BUY Open market or private purchase	$89,750 $3.59 p/Share	25,000 Added 12.72%	171,569 Voting Common Stock
Dec 23 2021	BUY Exercise of conversion of derivative security	$95,880 $1.97 p/Share	48,670 Added 24.93%	146,569 Voting Common Stock
Sep 08 2021	BUY Open market or private purchase	$96,030 $8.73 p/Share	11,000 Added 10.1%	97,899 Voting Common Stock

Also insider at

PTCT

PTC THERAPEUTICS, INC. Healthcare

RCKT

ROCKET PHARMACEUTICALS, INC. Healthcare

DPS